Naltrexone 6 mg once daily versus placebo in women with fibromyalgia: a randomised, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Naltrexone 6 mg once daily versus placebo in women with fibromyalgia: a randomised, double-blind, placebo-controlled trial

Published:2024-01 Issue:1 Volume:6 Page:e31-e39
ISSN:2665-9913
Container-title:The Lancet Rheumatology
language:en
Short-container-title:The Lancet Rheumatology

Author:

Due Bruun Karin,Christensen Robin,Amris Kirstine,Vaegter Henrik Bjarke,Blichfeldt-Eckhardt Morten Rune,Bye-Møller Lars,Holsgaard-Larsen Anders,Toft Palle

Funder

Gigtforeningen

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference30 articles.

1. Prevalence of fibromyalgia in general population and patients, a systematic review and meta-analysis;Heidari;Rheumatol Int,2017

2. Fibromyalgia diagnosis and biased assessment: sex, prevalence, and bias;Wolfe;PLoS One,2018

3. Performance of the 2016 diagnostic criteria for fibromyalgia in a tertiary care pain rehabilitation setting: a diagnostic accuracy study;Bruun;Scand J Pain,2021

4. Central sensitization in fibromyalgia? A systematic review on structural and functional brain MRI;Cagnie;Semin Arthritis Rheum,2014

5. Neurophysiological and psychosocial mechanisms of fibromyalgia: a comprehensive review and call for an integrative model;Pinto;Neurosci Biobehav Rev,2023

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Fibromyalgia: An Update;Biomedicines;2024-06-06

2. Low-dose naltrexone for post-COVID fatigue syndrome: a study protocol for a double-blind, randomised trial in British Columbia;BMJ Open;2024-05

3. “Fibromyalgia – are there any new approaches?”;Best Practice & Research Clinical Rheumatology;2024-03

4. Is low-dose naltrexone for fibromyalgia another treatment disappointment?;The Lancet Rheumatology;2024-01